Quantifying the potential benefit of CA 125 screening for ovarian cancer

This publication has 22 references indexed in Scilit:

• Prospective evaluation of serum CA 125 levels in a normal population, phase I: The specificities of single and serial determinations in testing for ovarian cancer
  Gynecologic Oncology, 1990
• Intraperitoneal radiolabeled OC125 in patients with advanced ovarian cancer
  Gynecologic Oncology, 1989
• Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer
  International Journal of Cancer, 1988
• An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma
  Gynecologic Oncology, 1988
• MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER
  The Lancet, 1988
• Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma
  Gynecologic Oncology, 1985
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell Types
  American Journal of Clinical Pathology, 1983
• A test of several parametric statistical models for estimating success rate in the treatment of carcinoma cervix uteri
  British Journal of Cancer, 1975
• Survival Curve for Cancer Patients Following Treatment
  Journal of the American Statistical Association, 1952